Vitamin D in Pregnancy and Childhood Asthma

  • , by SANUSq Research team
  • 9 min reading time
Vitamin D supplement during pregnancy

Could a mother's vitamin D during pregnancy give her baby some protection against asthma? Researchers have put the idea to the test.

Why pregnancy is a natural place to look

Asthma and wheezing often begin very early in life, which has led researchers to ask whether the groundwork for a child's airway health is partly laid before birth. Vitamin D is a plausible candidate: it helps regulate the immune system, and low vitamin D in pregnancy is common. The question is whether raising a mother's vitamin D during pregnancy makes any measurable difference to her child's chances of developing asthma or recurrent wheeze.

Encouragingly, this is one of those questions that has actually been tested in a proper randomised trial rather than left to observation alone.

In the VDAART randomised controlled trial, pregnant women at higher risk of having a child with asthma received either a higher or a standard dose of vitamin D. Asthma or recurrent wheeze in their children by age three was lower in the higher-dose group by about 6%, though this did not reach statistical significance — the trial may have been underpowered (Litonjua et al., 2016).

How vitamin D might influence a developing airway

To see why pregnancy was worth studying at all, it helps to know what vitamin D actually does. It behaves less like a simple vitamin and more like a hormone: once activated, it binds to receptors found on a wide range of cells, immune cells included, and influences which genes those cells switch on. One of its better-described roles is helping to keep immune responses proportionate — supporting the body's defences without letting inflammation run on unchecked.

Pregnancy is the window in which a baby's lungs and immune system are being built, and in which that immune system starts learning what to tolerate and what to react against. That is the reasoning behind the prenatal hypothesis: if vitamin D helps shape those early settings, a mother's status might leave some trace in how her child's airways behave later. It is a plausible idea rather than a proven one, which is exactly why it needed testing in a randomised trial rather than being assumed.

What the wider evidence adds

A single trial rarely settles a question, so it helps to look at the broader picture. When researchers combined the data from two similar randomised trials, the pooled result did point to a reduced risk of asthma or recurrent wheeze in early childhood — a more favourable signal than either trial showed alone. At the same time, longer follow-up of the children found that the early benefit appeared to fade by around age six. So the honest summary is: a promising early effect, strongest in the first years, with the long-term picture less clear.

This fits with the wider story of vitamin D and the airways, which we look at directly in vitamin D in asthma.

How to read a result like this

Findings in this area are easy to misread in either direction, so the language is worth unpacking. When a lower rate of asthma or wheeze in the higher-dose group is reported as not reaching statistical significance, that is not the same as finding no effect at all. It means the difference seen was not large enough, relative to the number of children studied, to rule out chance as the explanation. A trial that is underpowered — one that enrols fewer participants than would be needed to detect a modest effect reliably — can produce exactly this pattern: a result pointing in a promising direction without the statistical weight to confirm it. That is also why pooling two similar trials matters, since more children in the analysis makes a real but modest effect easier to see. And it is why the fading of the early signal by around age six deserves equal attention: the less convenient follow-up belongs in the summary just as much as the encouraging headline.

Where this fits in childhood asthma prevention

It is worth saying plainly that there is no single, reliable way to stop a child developing asthma. Childhood asthma prevention is not a solved problem, and the things that shape a child's risk are numerous and only partly modifiable: a family history of asthma, eczema or allergy; exposure to tobacco smoke before and after birth; being born prematurely or at a low birth weight; and the air a child grows up breathing.

Prenatal vitamin D belongs in that picture as one thread being researched, not as a lever that switches asthma off. The most useful things an expectant parent can do for a baby's future airways remain the well-established ones — avoiding tobacco smoke, attending antenatal appointments, eating well — with vitamin D status simply one more thing worth raising at those appointments.

What it means for expectant mothers

The practical takeaway is measured. This research does not mean vitamin D is a guaranteed way to prevent childhood asthma, and it is not a reason to take high doses on your own. What it reinforces is that vitamin D status matters in pregnancy for several reasons, and that it is worth discussing with your doctor or midwife, who can advise on the right approach and dose for you. The wider association between maternal vitamin D and child development is discussed in our piece on autism and vitamin D.

It also helps to know who tends to run low. Vitamin D is made in the skin on exposure to summer sunlight, so levels fall in people who get little of it: those living at higher latitudes or through a long winter, people with darker skin, anyone who covers up for cultural or practical reasons, and people who spend most of the day indoors. Pregnancy does not by itself cause a shortfall, but it does raise the stakes of having one, which is part of why the question comes up in antenatal care. If any of those describe you, that is a useful thing to mention at your next appointment rather than something to act on alone.

Frequently asked questions

Can vitamin D prevent childhood asthma if taken in pregnancy?

The evidence is promising but not conclusive. The main trial found a reduction in early childhood asthma or wheeze that did not reach statistical significance, while a combined analysis of two trials did point to a reduced risk. It is best seen as a supportive signal, not a guarantee.

How much vitamin D should I take in pregnancy?

That is a decision for your doctor or midwife, who can advise on the right dose for you based on standard recommendations and your own situation. Please don't self-prescribe high doses on the basis of this research.

Why might the effect fade as children get older?

Longer follow-up suggested the early benefit diminished by around age six. Asthma has many contributors as children grow, so an early nudge from prenatal vitamin D may simply be one of several factors that shape airway health over time.

Is low vitamin D common in pregnancy?

Yes, particularly where sunlight is limited. This is one reason prenatal care often pays attention to vitamin D, quite apart from the asthma question.

What does it mean that the result was not statistically significant?

It means the difference between the groups was not large enough, given the number of children studied, to rule out chance. It is a reason for caution rather than proof that nothing happened, and it is one reason researchers went on to combine the data from two trials for a clearer view.

Is anything known to reliably prevent childhood asthma?

Not at present. Risk is shaped by family history, exposure to tobacco smoke, prematurity and air quality, among other things, and no single measure removes it. Prenatal vitamin D is one research thread within that wider picture, not a solution to it.

What should I take away from this?

That vitamin D in pregnancy is worth attention for well-established reasons, and that any decisions about supplementation belong with your healthcare professional.

References

  1. Litonjua AA, Carey VJ, Laranjo N, et al. Effect of Prenatal Supplementation With Vitamin D on Asthma or Recurrent Wheezing in Offspring by Age 3 Years: The VDAART Randomized Clinical Trial. JAMA. 2016;315(4):362–70. PMID 26813209

Read more on the blog

Watch on YouTube

Explore more on our channel, @SANUSqHealthSupplements.

We wish you good health on your terms.
The team at SANUSq.

PS. Curious what's currently on offer? Take a look at our latest promotions.

The health information in this article is provided for educational purposes only. Consult your healthcare professional before making any medical decisions.

Regulatory Notice

The information on our websites, blogs, and emails is provided for informational purposes only and has not been evaluated by the EMA, EFSA, or FDA. It is not intended to replace medical advice provided by your healthcare professional, and is not intended to diagnose, treat, cure, or prevent any disease. Our products are intended for adults aged 18 and over. While the vitamins and supplements mentioned may offer various health benefits, supplements and dietary changes should be considered part of an overall health plan and not a substitute for professional medical treatment. Only a qualified healthcare professional can provide personalized advice and treatment plans based on your individual health needs and medical history; you should consult your healthcare professional before taking any product(s) if you are pregnant or breastfeeding.

Tags


SANUSq Health logo

© 2026 SANUSq Health EU, Powered by Shopify

    Login

    Forgot your password?

    Don't have an account yet?
    Create account